The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.
Academic rigor, journalistic flair
Articles on Insulin pricing
Displaying all articles
World Diabetes Day on Nov. 14 marks an increase in diabetes deaths and new diagnoses as the COVID-19 pandemic continues to hinder care for chronic conditions.
The present healthcare structure in Nigeria contributes to the suffering of people living with diabetes in the country.
World Diabetes Day provides an opportunity to look at the messaging around Walmart insulin, touted as a solution to soaring insulin prices. Cheaper insulins may not work as well for many people.
Top contributors
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Associate Professor of Communication Studies, Vanderbilt University
-
Assistant Professor of Clinical Pharmacy and Outcomes Sciences, University of South Carolina
-
Senior Lecturer and Consultant Endocrinologist, University of Ibadan
-
Executive Director of the Value of Life Sciences Innovation program; Fellow at the USC Schaeffer Center, University of Southern California
